HomeCLDX • NASDAQ
Celldex Therapeutics Inc
add
$24.99
5.00%
After Hours:(0.00%)0.00
$24.99
Closed: Aug 13, 5:33:37 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 730.00K | -70.78% |
Operating expense | 10.39M | 13.84% |
Net income | -56.60M | -57.92% |
Net profit margin | -7.75K | -440.37% |
Earnings per share | -0.85 | -57.41% |
EBITDA | -62.98M | -38.37% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 630.34M | -21.44% |
Total assets | 692.41M | -18.12% |
Total liabilities | 37.00M | 15.89% |
Total equity | 655.41M | — |
Shares outstanding | 66.41M | — |
Price to book | 2.41 | — |
Return on assets | -22.30% | — |
Return on capital | -23.39% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -56.60M | -57.92% |
Cash from operations | -44.01M | -50.05% |
Cash from investing | 49.85M | 206.69% |
Cash from financing | 63.00K | -98.30% |
Net change in cash | 5.91M | 108.17% |
Free cash flow | -27.27M | -55.43% |
Previous close
$23.80
Day range
$23.93 - $25.79
Year range
$14.40 - $47.00
Market cap
1.66B USD
Avg Volume
975.80K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1983
Headquarters
Website
Employees
186